RxDoctor Payments Data

Anthony Giampolo

Neurology · Somerset, PANPI 1730304403

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $137,475 of the $142,587 with a category attached, or 96.4%. Acadia Pharmaceuticals Inc accounts for 93.9% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $138,180 and has fallen 100.0% since, to $42 in 2025. Among neurology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$142,587in general payments, 2019–2025

Across 65 payments — averaging $2193.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$134K
  • Partner Therapeutics, Inc.$3K
  • Avanir Pharmaceuticals, Inc.$587
  • Sanofi$548
  • Amgen$539
  • Lilly USA, LLC$451
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$137,47596%
  • Travel & lodging$70%
  • Food & beverage$5,0634%
  • Education$420%

General payments by program year

19
20
21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,587 in reported general payments places this provider in the 90th percentile of 941 neurology providers in Pennsylvania.

See all neurology providers in Pennsylvania →

Other neurology in Somerset

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →